Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Lifestyle modifications as first-line treatment have paramount importance on the quality of life.
Read More »Impact of Physical Activity and Metformin on Postprandial Glucose
Managing Editor, Diabetes in Control
Skim Milk vs. Whole Milk: What’s the Healthier Option?
Does the fat content of dairy products play a role in the development of metabolic syndrome (MetS)?
Read More »Role of Magnesium in Type 2 Diabetes and Stroke
Adequate amounts of magnesium in the diet could reduce the risk of type 2 and cerebral vascular incidents.
Read More »Associations between Prediabetes and Vascular Complications
Do patients with prediabetes share the same vascular complication risk seen in patients with T2D?
Read More »Dulaglutide Can Reduce Cognitive Impairment in Patients with T2D
A recent exploratory analysis of the REWIND trial evaluated a potential additive benefit to using a once-weekly GLP-1 RA.
Read More »Prolonged Use of Proton Pump Inhibitors Linked to Increased Risk of T2DM
Long-term users of the acid reflux drugs known as Proton Pump Inhibitors (PPIs) have a 24% higher risk of developing type 2 diabetes than non-PPI users.
Read More »Old vs. New: Which T2D Agents Have the Best Renal Outcomes?
How do DPP-4 inhibitors and sulfonylureas compare to SGLT2is and GLP-1 agonists regarding renal outcomes?
Read More »Another Oral Combination Antidiabetic Agent
Dual and triple therapy just got a little easier.
Read More »Real-World Evidence in Support of Continuous Glucose Monitoring
Insulin delivery method or blood glucose monitoring – which is more important?
Read More »The VERTIS CV Study – SGLT-2 Inhibitors’ Cardiovascular and Renal Outcomes in T2D
This article is part of a live interview with Dr. Engel, Associate Vice President, Cardiometabolic and Women's Health, Merck Research Laboratories.
Read More »